Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026
The amending instrument that removed approvals in principle from the pathology laboratory approval machinery, substituted the Sixth Edition 2026 information communication and reporting standard from 13 July 2026, and substitutes the Sixth Edition 2026 in-house IVD standard from 1 July 2027.
Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 is a compliance framework from Australia (Commonwealth) with 4 domains and 15 controls. The largest domains are Schedule 1 Part 1, items 1 to 8: the approval machinery – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (8 controls), Sections 1 to 4: name, commencement, authority and the Schedule – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (4 controls), Schedule 1 Part 1, items 9 and 10: the incorporated standards – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (2 controls). Every control below carries what it requires and what an assessor expects to see.
Framework summaries on this platform are interpretations grounded in the published source, for educational and compliance planning purposes. They do not reproduce or replace the official standards. Refer to the authoritative source for the definitive text. Framework names and trademarks belong to their respective organisations.
Framework Domains (4)
Schedule 1 Part 1, items 1 to 8: the approval machinery – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026
Schedule 1 Part 1, items 9 and 10: the incorporated standards – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026
| Code | Title |
|---|---|
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::part1-icr-standard | The information, communication and reporting standard |
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::part1-standards-note | The free-access note |
Schedule 1 Part 2, item 11: the in-house IVD standard from 1 July 2027 – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026
| Code | Title |
|---|---|
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::part2-in-house-ivd | The in-house IVD standard |
Sections 1 to 4: name, commencement, authority and the Schedule – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026
| Code | Title |
|---|---|
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::s1-name | Name of the instrument |
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::s2-commencement | Commencement |
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::s3-authority | Authority |
| australia-health-insurance-accredited-pathology-laboratories-approval-amendment-relevant-standards-principles-no-3-2026::s4-schedules | Schedules |
What is Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 and who does it apply to?
Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 is a compliance framework from Australia (Commonwealth) with 4 domains and 15 controls. The amending instrument that removed approvals in principle from the pathology laboratory approval machinery, substituted the Sixth Edition 2026 information communication and reporting standard from 13 July 2026, and substitutes the Sixth Edition 2026 in-house IVD standard from 1 July 2027. It is used by organisations to establish and maintain compliance with industry standards and regulatory requirements.
What does Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 actually require?
Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 has 15 controls organised across 4 domains. The largest domains are Schedule 1 Part 1, items 1 to 8: the approval machinery – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (8 controls), Sections 1 to 4: name, commencement, authority and the Schedule – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (4 controls), Schedule 1 Part 1, items 9 and 10: the incorporated standards – Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 (2 controls). Each control defines specific requirements that organisations must implement to achieve compliance.
If I already comply with another framework, how much of Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 do I already cover?
Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 does not currently have cross-framework mappings in our system. Check back as we continuously expand our mapping database.
How do I implement Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026?
Start your Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 compliance journey by running a self-assessment on our platform to identify your current compliance posture. Our AI advisory can answer specific questions about Australia Health Insurance (Accredited Pathology Laboratories, Approval) Amendment (Relevant Standards) Principles (No. 3) 2026 requirements, and cross-framework mapping helps you leverage existing controls from other frameworks you may already comply with. Create a free account to access all 15 controls and track your progress.
Start Your Compliance Journey
Create a free account to run self-assessments, get AI advisory, and track your compliance progress across 1,074 frameworks.
Get Started Free →Free forever, no credit card required